secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001607062-23-000078
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma files 1-for-1500 reverse stock split and reduces preferred voting power
--------------------------------------------------------------------------------

- Series AA preferred votes reduced to 7 per share; Series NC to 334 per share, effective March 6, 2023.
- 1-for-1500 reverse stock split authorized for all common and preferred stock, effective March 6, 2023.
- Reverse split consolidates shares at a 1500:1 ratio, drastically reducing outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000078/0001607062-23-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000078/rgbp020623form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-23-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer